nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CTSK—periosteum—cleft lip	0.176	0.253	CbGeAlD
Telaprevir—CTSK—skull—cleft lip	0.145	0.208	CbGeAlD
Telaprevir—CTSK—cartilage tissue—cleft lip	0.123	0.177	CbGeAlD
Telaprevir—CELA1—head—cleft lip	0.0539	0.0775	CbGeAlD
Telaprevir—CTSK—mouth—cleft lip	0.0501	0.072	CbGeAlD
Telaprevir—CTSS—mouth—cleft lip	0.0439	0.0631	CbGeAlD
Telaprevir—CTSS—embryo—cleft lip	0.0313	0.045	CbGeAlD
Telaprevir—CTSS—telencephalon—cleft lip	0.0254	0.0366	CbGeAlD
Telaprevir—CMA1—ACE Inhibitor Pathway—NOS3—cleft lip	0.0185	0.0609	CbGpPWpGaD
Telaprevir—CTSK—head—cleft lip	0.0181	0.026	CbGeAlD
Telaprevir—CTSS—head—cleft lip	0.0158	0.0228	CbGeAlD
Telaprevir—CMA1—Signaling by SCF-KIT—FGF7—cleft lip	0.0103	0.0337	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—TGFB3—cleft lip	0.0099	0.0325	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGF8—cleft lip	0.00946	0.0311	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—BHMT2—cleft lip	0.00904	0.0297	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—MTHFS—cleft lip	0.00903	0.0296	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TGFB3—cleft lip	0.00883	0.029	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGF3—cleft lip	0.0077	0.0253	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGF9—cleft lip	0.00751	0.0247	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB3—cleft lip	0.00727	0.0239	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—NANS—cleft lip	0.0065	0.0213	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGF10—cleft lip	0.00633	0.0208	CbGpPWpGaD
Telaprevir—ABCB1—ABC-family proteins mediated transport—ABCA4—cleft lip	0.00627	0.0206	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—BMP4—cleft lip	0.00553	0.0182	CbGpPWpGaD
Telaprevir—ABCB1—embryo—cleft lip	0.00552	0.00794	CbGeAlD
Telaprevir—CMA1—Signaling by SCF-KIT—FGFR2—cleft lip	0.00508	0.0167	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—BMP4—cleft lip	0.00493	0.0162	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGFR1—cleft lip	0.00474	0.0156	CbGpPWpGaD
Telaprevir—ABCB1—telencephalon—cleft lip	0.00449	0.00645	CbGeAlD
Telaprevir—CMA1—Signaling by SCF-KIT—FGFR3—cleft lip	0.00448	0.0147	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ARHGAP29—cleft lip	0.00434	0.0143	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TCN2—cleft lip	0.00411	0.0135	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—BMP4—cleft lip	0.00406	0.0133	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SLC19A1—cleft lip	0.00403	0.0132	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB3—cleft lip	0.00355	0.0117	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGF2—cleft lip	0.00346	0.0114	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB3—cleft lip	0.00339	0.0111	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—SUMO1—cleft lip	0.00317	0.0104	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGF7—cleft lip	0.00296	0.00972	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—MTR—cleft lip	0.00285	0.00934	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGF7—cleft lip	0.00284	0.00933	CbGpPWpGaD
Telaprevir—ABCB1—head—cleft lip	0.00279	0.00402	CbGeAlD
Telaprevir—CTSK—Immune System—IRF6—cleft lip	0.00275	0.00903	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGF8—cleft lip	0.00273	0.00897	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGF8—cleft lip	0.00262	0.00861	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGF7—cleft lip	0.00244	0.008	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—WNT9B—cleft lip	0.00238	0.00782	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGF7—cleft lip	0.00234	0.00768	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—MTR—cleft lip	0.00232	0.0076	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOG—cleft lip	0.00228	0.00749	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IRF6—cleft lip	0.00226	0.00744	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGF8—cleft lip	0.00225	0.00739	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGF3—cleft lip	0.00222	0.0073	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGF9—cleft lip	0.00217	0.00712	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGF8—cleft lip	0.00216	0.00709	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGF3—cleft lip	0.00214	0.00701	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ABCA4—cleft lip	0.00212	0.00697	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—FGF2—cleft lip	0.00209	0.00688	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGF9—cleft lip	0.00208	0.00684	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—WNT3—cleft lip	0.00189	0.00621	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SUMO1—cleft lip	0.00188	0.00619	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—FGF2—cleft lip	0.00187	0.00613	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—MTR—cleft lip	0.00184	0.00604	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGF3—cleft lip	0.00183	0.00601	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGF10—cleft lip	0.00183	0.006	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGF9—cleft lip	0.00179	0.00586	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGF3—cleft lip	0.00176	0.00577	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGF10—cleft lip	0.00176	0.00577	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGF7—cleft lip	0.00172	0.00566	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGF9—cleft lip	0.00171	0.00563	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGF8—cleft lip	0.00159	0.00522	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.00158	0.00518	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SUMO1—cleft lip	0.00155	0.0051	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—FGF2—cleft lip	0.00154	0.00505	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—MTHFR—cleft lip	0.00152	0.005	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGF10—cleft lip	0.00151	0.00494	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGFR2—cleft lip	0.00147	0.00482	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGF10—cleft lip	0.00145	0.00475	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGF7—cleft lip	0.00142	0.00466	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGFR2—cleft lip	0.00141	0.00463	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGFR1—cleft lip	0.00137	0.00449	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGFR1—cleft lip	0.00131	0.00431	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGF8—cleft lip	0.00131	0.0043	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGF3—cleft lip	0.0013	0.00425	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGFR3—cleft lip	0.00129	0.00424	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGF9—cleft lip	0.00126	0.00415	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00125	0.00411	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SPRY2—cleft lip	0.00125	0.00411	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGF7—cleft lip	0.00125	0.00411	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGFR3—cleft lip	0.00124	0.00408	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—MTHFR—cleft lip	0.00124	0.00407	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGFR2—cleft lip	0.00121	0.00397	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGFR2—cleft lip	0.00116	0.00381	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGF8—cleft lip	0.00115	0.00379	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGFR1—cleft lip	0.00113	0.0037	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGFR1—cleft lip	0.00108	0.00355	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGF3—cleft lip	0.00107	0.0035	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGF10—cleft lip	0.00107	0.0035	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGFR3—cleft lip	0.00106	0.00349	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGF9—cleft lip	0.00104	0.00341	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTCH1—cleft lip	0.00104	0.0034	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGFR3—cleft lip	0.00102	0.00336	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGF2—cleft lip	0.000999	0.00328	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	0.000985	0.00323	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGF2—cleft lip	0.000959	0.00315	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGF3—cleft lip	0.000939	0.00308	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGF9—cleft lip	0.000916	0.00301	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGF10—cleft lip	0.000877	0.00288	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGFR2—cleft lip	0.000855	0.00281	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGF2—cleft lip	0.000823	0.0027	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB3—cleft lip	0.000812	0.00267	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGFR1—cleft lip	0.000797	0.00262	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGF2—cleft lip	0.00079	0.00259	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGF10—cleft lip	0.000773	0.00254	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGFR3—cleft lip	0.000753	0.00247	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000748	0.00246	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGFR2—cleft lip	0.000704	0.00231	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGFR1—cleft lip	0.000656	0.00215	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000655	0.00215	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.000637	0.00209	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGFR3—cleft lip	0.00062	0.00204	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGFR2—cleft lip	0.00062	0.00204	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGF2—cleft lip	0.000582	0.00191	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—MTR—cleft lip	0.000581	0.00191	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGFR1—cleft lip	0.000578	0.0019	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGFR3—cleft lip	0.000546	0.00179	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000531	0.00175	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGF2—cleft lip	0.000479	0.00157	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00045	0.00148	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGF2—cleft lip	0.000422	0.00139	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOS3—cleft lip	0.000416	0.00137	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000328	0.00108	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC19A1—cleft lip	0.00032	0.00105	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC19A1—cleft lip	0.000281	0.000922	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—cleft lip	0.000276	0.000906	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TCN2—cleft lip	0.000266	0.000872	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TCN2—cleft lip	0.000233	0.000764	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000215	0.000705	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTR—cleft lip	0.000184	0.000604	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000173	0.000568	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS3—cleft lip	0.00017	0.000557	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTR—cleft lip	0.000161	0.000529	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TCN2—cleft lip	0.000143	0.000471	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—cleft lip	0.000113	0.00037	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTR—cleft lip	9.93e-05	0.000326	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—cleft lip	9.88e-05	0.000325	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—cleft lip	9.85e-05	0.000324	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—cleft lip	8.63e-05	0.000283	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NOS3—cleft lip	6.87e-05	0.000226	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—cleft lip	6.09e-05	0.0002	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NOS3—cleft lip	6.02e-05	0.000198	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—cleft lip	5.32e-05	0.000175	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NOS3—cleft lip	3.71e-05	0.000122	CbGpPWpGaD
